2022 American Transplant Congress
Pediatric Acute Liver Failure: Patient Factors Associated with Higher Mortality
*Purpose: Pediatric acute liver failure (PALF) is characterized by sudden onset deteriorating liver function, progressive coagulopathy, and hepatic encephalopathy in previously healthy children. The clinical…2022 American Transplant Congress
Incidence and Laterality of Pulmonary Emboli in Single Lung Transplant Recipients
*Purpose: Lung transplantation surgery increases the risk of pulmonary embolism (PE), with an incidence described between 6% to 27%, based on data from 15 years…2022 American Transplant Congress
Temporal Trends in Utilization, Discard, and Outcomes for Extended Criteria Donor Lungs
1Johns Hopkins, Baltimore, MD, 2Baylor, Houston, TX
*Purpose: Extended criteria donor lungs (ECDL) are defined as those failing to meet ≥1 standard donor criteria (P/F > 300, age < 55, smoking <…2022 American Transplant Congress
Dd-cfdna Correlates With Acute Rejection In The Setting Of Bk Viremia After Kidney Transplantation
1NYU Langone Transplant Institute, New York, NY, 2CareDx, Brooklyn, NY
*Purpose: BK virus reactivation is common among kidney transplant recipients (KTRs) and is a risk factor for allograft loss. Currently, there is no clearly established…2022 American Transplant Congress
Early Clinical Complications Following HLA-Incompatible Living Donor Kidney Transplantation
1Johns Hopkins University, Baltimore, MD, 2University of Wisconsin-Madison, Madison, WI
*Purpose: Incompatible living donor kidney transplant recipients (ILDKTr) require desensitization to facilitate transplantation across donor-specific antibody (DSA); however, this substantial upfront immunosuppression may result in…2022 American Transplant Congress
Conversion to Belatacept for Calcineurin Inhibitor Toxicities
Columbia University Medical Center, New York, NY
*Purpose: Calcineurin inhibitors (CNIs) have improved renal transplant (RTx) outcomes but are associated with significant toxicities. Belatacept provides better long-term outcomes than cyclosporine, has less…2022 American Transplant Congress
Outcomes of Primary Simultaneous Pancreas-Kidney Transplants by Induction Agent in the United States
*Purpose: Induction immunosuppression choice for simultaneous pancreas-kidney (SPK) transplants varies widely in the United States. We examined the association between induction agents and outcomes of…2022 American Transplant Congress
Navigating the Ethics of Transplant Research Involving Newly Deceased
*Purpose: The most promising innovations for overcoming the organ shortage include novel organ sources such as xenotransplant and bioengineered organs. Studying these organs in mechanically…2022 American Transplant Congress
External Validation of the Abbreviated Ibox Scoring System at One-Year Post Kidney Transplant as a Surrogate Endpoint for Death-Censored Graft Survival
*Purpose: The Transplant Therapeutics Consortium seeks to translate the iBox from Loupy et al., 2019 into a surrogate endpoint for five-year death-censored graft survival after…2022 American Transplant Congress
Performance of Race-Independent GFR Estimating Formulas, CKD-EPI2021 and NMR-GFR Post Kidney Transplantation
*Purpose: Progressive GFR decline post kidney transplantation is a general problem that requires accurate assessment of GFR for clinical decision making. The gold-standard radiotracer determined…
American Transplant Congress abstracts